The agency approved Actavis Plc's Dalvance in May, Cubists' Sivextro in June and The Medicines Co's Orbactiv in August. Cubist has earlier said it expects European approval for Zerbaxa during the second half of 2015. Zerbaxa is expected to be priced around $5,000-$6,000 per patient, analysts including Koffler said. However, the drug would be used selectively at first as it will cost more, she added. 
1 In the same trial, patients with CrCl 30 to ≤ 50 mL/min had a clinical cure rate of 47.8% when treated with ZERBAXA plus metronidazole vs 69.2% when treated with meropenem. 2  A similar trend was also seen in the cUTI trial. 1 In a clinical trial, patients with cIAIs with CrCl ≥ 50 mL/min had a clinical cure rate of 85.2% when treated with ZERBAXA plus metronidazole vs 87.9
1 A typical prescription may cost $94 or more for 1 vial of Zerbaxa 1g/0.5g. 2  You cannot fill this prescription in a regular pharmacy. 3  Your doctor, hospital, or clinic will provide this medication. 4  This drug is likely to be covered under your medical benefit if you have insurance. This prescription is provided by a doctor and is generally not available at a pharmacy. This drug is administered by your healthcare practitioner (HCP), which usually means: 1  It may be expensive. 2  A typical prescription may cost $94 or more for 1 vial of Zerbaxa 1g/0.5g.
The average wholesale price of Zerbaxa per vial is $83 and per cartoon (10 vial) is $830. How to obtain prescription cost assistance for Zerbaxa. To receive prescription cost assistance visit AccessZERBAXA. 1 Zerbaxa 375 mg IV every 8 hours for patients with CrCl 15 to 29 ml/min. 2  End-stage renal disease (ESRD) patients on hemodialysis: A loading dose of Zerbaxa 750 mg IV with a maintenance dose of 150 mg, every 8 hours.
Recommended Dosage. The recommended dosage regimen is ZERBAXA 1.5 gram (g) (ceftolozane 1 g and tazobactam 0.5 g) for injection administered every 8 hours by intravenous infusion over 1 hour in patients 18 years or older and with normal renal function or mild renal impairment. 
1 It may be expensive. 2  A typical prescription may cost $94 or more for 1 vial of Zerbaxa 1g/0.5g. 3  You cannot fill this prescription in a regular pharmacy. 4  Your doctor, hospital, or clinic will provide this medication. 5  This drug is likely to be covered under your medical benefit if you have insurance. This prescription is provided by a doctor and is generally not available at a pharmacy. This drug is administered by your healthcare practitioner (HCP), which usually means: 1  It may be expensive. 2  A typical prescription may cost $94 or more for 1 vial of Zerbaxa 1g/0.5g.
A total of 1068 adults hospitalized with cUTI including pyelonephritis received Zerbaxa 1.5 g (1 g/0.5 g IV) every 8 hours or levofloxacin (750 mg IV) once daily for 7 days. 1 Zerbaxa 375 mg IV every 8 hours for patients with CrCl 15 to 29 ml/min. 2  End-stage renal disease (ESRD) patients on hemodialysis: A loading dose of Zerbaxa 750 mg IV with a maintenance dose of 150 mg, every 8 hours.
1 Zerbaxa 750 mg IV every 8 hours for patients with CrCl 30 to 50 ml/min. 2  Zerbaxa 375 mg IV every 8 hours for patients with CrCl 15 to 29 ml/min. 3  End-stage renal disease (ESRD) patients on hemodialysis: A loading dose of Zerbaxa 750 mg IV with a maintenance dose of 150 mg, every 8 hours. 1 Zerbaxa 375 mg IV every 8 hours for patients with CrCl 15 to 29 ml/min. 2
A total of 979 adults hospitalized with cIAI received Zerbaxa 1.5 g (1 g/0.5 g IV) plus metronidazole (500 mg IV) or meropenem (1 g IV) for 4 to 14 days. The clinical cure rates at 24 to 32 days after initiation of therapy, were 83% in Zerbaxa and metronidazole arm and 87.3% in the meropenem arm. 1 Zerbaxa 375 mg IV every 8 hours for patients with CrCl 15 to 29 ml/min. 2  End-stage renal disease (ESRD) patients on hemodialysis: A loading dose of Zerbaxa 750 mg IV with a maintenance dose of 150 mg, every 8 hours.